ID

13604

Beschreibung

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00513305

Link

https://clinicaltrials.gov/show/NCT00513305

Stichworte

  1. 19.02.16 19.02.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

19. Februar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Myeloid Leukemia NCT00513305

Eligibility Acute Myeloid Leukemia NCT00513305

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient has confirmed acute myeloid leukemia (aml).
Beschreibung

the patient has confirmed acute myeloid leukemia (aml).

Datentyp

boolean

Alias
UMLS CUI [1]
C0023467
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
Beschreibung

the patient is unwilling or unable to tolerate conventional induction chemotherapy.

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
Beschreibung

the patient has no comorbid conditions that would limit life expectancy to less than 3 months.

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
patient must meet specific laboratory parameters for study inclusion.
Beschreibung

patient must meet specific laboratory parameters for study inclusion.

Datentyp

boolean

Alias
UMLS CUI [1]
C0022885
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
Beschreibung

the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205156
previous treatment with low-dose cytarabine is not permitted.
Beschreibung

previous treatment with low-dose cytarabine is not permitted.

Datentyp

boolean

Alias
UMLS CUI [1]
C0010711
the patient has a qt interval outside of the protocol-specified range.
Beschreibung

the patient has a qt interval outside of the protocol-specified range.

Datentyp

boolean

Alias
UMLS CUI [1]
C0429028
the patient has laboratory values outside of protocol-specified ranges.
Beschreibung

the patient has laboratory values outside of protocol-specified ranges.

Datentyp

boolean

Alias
UMLS CUI [1]
C0022885
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Beschreibung

the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.

Datentyp

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C0851346
UMLS CUI [3]
C1875319
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
Beschreibung

the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
the patient has known central nervous system involvement with aml.
Beschreibung

the patient has known central nervous system involvement with aml.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0449389

Ähnliche Modelle

Eligibility Acute Myeloid Leukemia NCT00513305

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
acute myeloid leukemia
Item
the patient has confirmed acute myeloid leukemia (aml).
boolean
C0023467 (UMLS CUI [1])
conventional induction chemotherapy
Item
the patient is unwilling or unable to tolerate conventional induction chemotherapy.
boolean
C0392920 (UMLS CUI [1])
life expectancy
Item
the patient has no comorbid conditions that would limit life expectancy to less than 3 months.
boolean
C0023671 (UMLS CUI [1])
laboratory parameters
Item
patient must meet specific laboratory parameters for study inclusion.
boolean
C0022885 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy
Item
the patient has had previous cytotoxic chemotherapy for acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
boolean
C0392920 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
cytarabine
Item
previous treatment with low-dose cytarabine is not permitted.
boolean
C0010711 (UMLS CUI [1])
qt interval
Item
the patient has a qt interval outside of the protocol-specified range.
boolean
C0429028 (UMLS CUI [1])
laboratory values
Item
the patient has laboratory values outside of protocol-specified ranges.
boolean
C0022885 (UMLS CUI [1])
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
Item
the patient is concurrently treated with cytotoxic therapy, radiation, or investigational agents.
boolean
C0677881 (UMLS CUI [1])
C0851346 (UMLS CUI [2])
C1875319 (UMLS CUI [3])
comorbidity
Item
the patient has uncontrolled, severe cardiovascular or pulmonary disease or other uncontrolled medical condition.
boolean
C0009488 (UMLS CUI [1])
central nervous system involvement
Item
the patient has known central nervous system involvement with aml.
boolean
C0023467 (UMLS CUI [1,1])
C0449389 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video